NPM1 and acute myeloid leukemia: 2.8. A Multivariate Analysis Confirms PTK2 Overexpression as an Independent Prognostic Factor for OS and DFS in Cytogenetic IR-AML Patients with Non-Favorable FLT3/NPM1 Combinations and PTK2B or LYN Underexpression